[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @bio_report BioReport BioReport posts on X about $srpt, money, $mygn, market cap the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::2933996796/interactions)  - X Week XXXXXX +1,465% - X Month XXXXXX -XX% - X Months XXXXXXX -XX% - X Year XXXXXXX +612% ### Mentions: XX [#](/creator/twitter::2933996796/posts_active)  - X Months XXX -XX% - X Year XXX +283% ### Followers: XXXXX [#](/creator/twitter::2933996796/followers)  - X Week XXXXX +1.90% - X Month XXXXX +4.10% - X Months XXXXX +30% - X Year XXXXX +88% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::2933996796/influencer_rank)  ### Social Influence [#](/creator/twitter::2933996796/influence) --- **Social category influence** [finance](/list/finance) [stocks](/list/stocks) [ncaa football](/list/ncaa-football) **Social topic influence** [$srpt](/topic/$srpt), [money](/topic/money), [$mygn](/topic/$mygn) #1, [market cap](/topic/market-cap), [$mdgl](/topic/$mdgl), [pricing](/topic/pricing), [$lnth](/topic/$lnth), [100m](/topic/100m), [$100m](/topic/$100m), [accounting](/topic/accounting) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Lantheus Holdings, Inc (LNTH)](/topic/$lnth) [Hundred Million (100M)](/topic/$100m) [Elevance Health Inc (ELV)](/topic/$elv) ### Top Social Posts [#](/creator/twitter::2933996796/posts) --- Top posts by engagements in the last XX hours "$LNTH a bit odd of a drop on CMS update considering most always thought next year would use median cost pricing which is the current way"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1945903938697617566) 2025-07-17 17:50:26 UTC 1149 followers, XXX engagements "$MYGN at these prices Im taking any leftover money and buying in bulk. Solid company with loyal customer base in hereditary cancer. Shares priced as if they make $100M in revenue"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1946230629584318469) 2025-07-18 15:28:35 UTC 1153 followers, XXX engagements "$SRPT down on a patient death unrelated to DMD and in a discontinued program. Not sure the concern business wise"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1946044474217664824) 2025-07-18 03:08:53 UTC 1153 followers, 2625 engagements "@Kevin_W81 Well to be fair has a masters in accounting from USC as well"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1945701041183588604) 2025-07-17 04:24:12 UTC 1148 followers, XX engagements "$SRPT overhang should now be removed. Elevidys not being removed from market and company still at $X billion run rate"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1945689406180131087) 2025-07-17 03:37:58 UTC 1152 followers, 2435 engagements "@yaireinhorn @Sarepta @CNBC @angelicapeebles @CNBCFastMoney @SquawkCNBC @CNBCi Not sure how its the end of the company with a billion dollar Exon skipping business"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1946661103003726289) 2025-07-19 19:59:08 UTC 1153 followers, XX engagements "$SRPT so company will be making almost a billion in profit a year and market cap is under $X billion. Hmmm"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1945830052270379354) 2025-07-17 12:56:50 UTC 1153 followers, 6611 engagements "$MYGN just a reminder how silly the stock price is under $500M market cap. Last year it was multi-billion. Revenue 2025E $807-823M 2024 $837M 2023 $753M 2022 $678M 2021 $690M"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1946231287796379660) 2025-07-18 15:31:12 UTC 1153 followers, XXX engagements "Biotech portfolio finally starting to turn around with $SRPT $AVDL $MDGL. Next up is $MYGN"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1945701317974085666) 2025-07-17 04:25:18 UTC 1153 followers, XXX engagements "Theres no path that doesnt lead to $MDGL being a multi billion dollar revenue company. Still think we see it acquired around $XXX a share soon and that would be a steal"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1940071345137885457) 2025-07-01 15:33:48 UTC 1148 followers, 4518 engagements "$ELV the drop appears way overdone at this point. Insurance companies arent in the business to lose money and will adjust by raising premiums on areas they need to. Bumps along the ways but much more often than not they bounce back"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1946229192900976785) 2025-07-18 15:22:53 UTC 1152 followers, XXX engagements "@justinamash Would be easier for him to release them than writing lengthy tweets about it"  [@bio_report](/creator/x/bio_report) on [X](/post/tweet/1945706716215263741) 2025-07-17 04:46:45 UTC 1148 followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@bio_report BioReport
BioReport posts on X about $srpt, money, $mygn, market cap the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX +1,465%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +612%
Mentions: XX #
- X Months XXX -XX%
- X Year XXX +283%
Followers: XXXXX #
- X Week XXXXX +1.90%
- X Month XXXXX +4.10%
- X Months XXXXX +30%
- X Year XXXXX +88%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance stocks ncaa football
Social topic influence $srpt, money, $mygn #1, market cap, $mdgl, pricing, $lnth, 100m, $100m, accounting
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Lantheus Holdings, Inc (LNTH) Hundred Million (100M) Elevance Health Inc (ELV)
Top Social Posts #
Top posts by engagements in the last XX hours
"$LNTH a bit odd of a drop on CMS update considering most always thought next year would use median cost pricing which is the current way"
@bio_report on X 2025-07-17 17:50:26 UTC 1149 followers, XXX engagements
"$MYGN at these prices Im taking any leftover money and buying in bulk. Solid company with loyal customer base in hereditary cancer. Shares priced as if they make $100M in revenue" @bio_report on X 2025-07-18 15:28:35 UTC 1153 followers, XXX engagements
"$SRPT down on a patient death unrelated to DMD and in a discontinued program. Not sure the concern business wise" @bio_report on X 2025-07-18 03:08:53 UTC 1153 followers, 2625 engagements
"@Kevin_W81 Well to be fair has a masters in accounting from USC as well" @bio_report on X 2025-07-17 04:24:12 UTC 1148 followers, XX engagements
"$SRPT overhang should now be removed. Elevidys not being removed from market and company still at $X billion run rate" @bio_report on X 2025-07-17 03:37:58 UTC 1152 followers, 2435 engagements
"@yaireinhorn @Sarepta @CNBC @angelicapeebles @CNBCFastMoney @SquawkCNBC @CNBCi Not sure how its the end of the company with a billion dollar Exon skipping business" @bio_report on X 2025-07-19 19:59:08 UTC 1153 followers, XX engagements
"$SRPT so company will be making almost a billion in profit a year and market cap is under $X billion. Hmmm" @bio_report on X 2025-07-17 12:56:50 UTC 1153 followers, 6611 engagements
"$MYGN just a reminder how silly the stock price is under $500M market cap. Last year it was multi-billion. Revenue 2025E $807-823M 2024 $837M 2023 $753M 2022 $678M 2021 $690M" @bio_report on X 2025-07-18 15:31:12 UTC 1153 followers, XXX engagements
"Biotech portfolio finally starting to turn around with $SRPT $AVDL $MDGL. Next up is $MYGN" @bio_report on X 2025-07-17 04:25:18 UTC 1153 followers, XXX engagements
"Theres no path that doesnt lead to $MDGL being a multi billion dollar revenue company. Still think we see it acquired around $XXX a share soon and that would be a steal" @bio_report on X 2025-07-01 15:33:48 UTC 1148 followers, 4518 engagements
"$ELV the drop appears way overdone at this point. Insurance companies arent in the business to lose money and will adjust by raising premiums on areas they need to. Bumps along the ways but much more often than not they bounce back" @bio_report on X 2025-07-18 15:22:53 UTC 1152 followers, XXX engagements
"@justinamash Would be easier for him to release them than writing lengthy tweets about it" @bio_report on X 2025-07-17 04:46:45 UTC 1148 followers, XX engagements